Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market
Advertisement

Tango Therapeutics (TNGX) Revenue

Compare
410 Followers

Tango Therapeutics Revenue

Tango Therapeutics had a revenue of 53.81M in the quarter ending Sep 30, 2025, with 1591.64%. This bring the company's revenue in the last twelve months to 66.50M, Decreased 173.70%. In the fiscal year ending Dec 31, 2024, Tango Therapeutics had annual revenue of 42.07M with 15.17% growth.
Revenue (ttm)
66.50M
Revenue Growth
53.28%
P/S Ratio
26.14
Revenue/Employee
$271,413
Employees
155
Market Cap
$1.10B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
42.07M5.54M+115.17%
Dec 31, 2023
36.53M11.67M+146.93%
Dec 31, 2022
24.86M-12.18M+67.11%
Dec 31, 2021
37.04M29.39M+483.83%
Dec 31, 2020
7.66M-16.99M+31.06%
Dec 31, 2019
24.65M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis